Navigation Links
Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014
Date:7/31/2014

SAN FRANCISCO, July 31, 2014 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the second quarter ended June 30, 2014.

Cash and investments in marketable securities at June 30, 2014 were $301.4 million as compared to $309.1 million at March 31, 2014."The second half of 2014 will be an exciting time for Nektar as we look forward to significant milestones for a number of our late-stage clinical programs," said Howard W. Robin, President and Chief Executive Officer of Nektar. "The first of these is the potential US and EU approvals of Movantik™ with our partner AstraZeneca. If approved, Movantik would be the first oral targeted therapy approved for opioid induced constipation, a debilitating condition that occurs in up to 80%* of the 69 million chronic pain patients worldwide. Our partner Baxter has completed dosing in their Phase 3 study for BAX 855, a longer-acting PEGylated Factor VIII therapy to treat hemophilia A and plans to file the BLA in the U.S. by the end of this year. In our proprietary pipeline, we are on track for topline results from the Phase 3 breast cancer study for NKTR-102 in Q1 2015."

Revenue in the second quarter of 2014 was $28.5 million as compared to $33.9 million in the second quarter of 2013. Year-to-date revenue for 2014 was $48.3 million as compared to $56.9 million in the first half of 2013.  The decrease in revenue in the second quarter and first half of 2014 as compared to the same periods in 2013 is primarily due to decreased manufacturing activity.  Revenue included non-cash royalty revenue, related to our 2012 royalty monetization, of $4.8 million and $10.6 million in the second quarter and first half of 2014, respectively, and $3.8 million and $8.2 million in the second quarter and first half of 2013, respectively. This non-cash royalty revenue is offset by non-cash interest exp
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA
3. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
4. Nektar to Announce Financial Results for the Third Quarter of 2013 on Thursday, November 7, 2013, After Close of U.S.-Based Financial Markets
5. Nektar Reports that Partner AstraZeneca Announced European Medicines Agency Acceptance of Marketing Authorisation Application for Naloxegol
6. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2013
7. Nektar to Announce Financial Results for the Second Quarter of 2013 on Thursday, August 8, 2013, After Close of U.S.-Based Financial Markets
8. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
9. Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
10. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
11. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Sept. 18, 2014   Fruit Street Health ... initial seed round of funding. The ... by a series of individual investors, the majority of ... in the initial round are; Houston Cardiology Consultants ... Urologist Stacy Childs, Rapha Family Medicine Practice Owner ...
(Date:9/18/2014)... 2014  Decision Resources Group finds that Regeneron,s Eylea, ... agent for wet AMD, is equally likely to be ... Lucentis, which is the standard of care for wet ... directors do not identify a clear clinical or economic ... Lucentis to be listed on tier 1 or 2 ...
(Date:9/18/2014)...  A $3 million grant from The Glenn Foundation ... to establish a national center of excellence in biogerontology ... Research at U-M will focus on exploiting and expanding ... of aging and postpone diseases in animal models. Researchers ... develop medications that may help people live longer, healthier ...
Breaking Medicine Technology:Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 2Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 3Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD 2Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD 3$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 2$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 3
(Date:9/18/2014)... September 19, 2014 When Mary Ann Thompson and ... couple, who live in Bali, Indonesia with their son, Isaac, said ... The two met at Mercy College in 2001 when Thompson was ... who was a graduate student at the time, was French and ... Jamaica and migrated to the United States when she was 7 ...
(Date:9/18/2014)... September 18, 2014 Kent, WA Chiropractor ... Chiropractic are pleased to announce that Dawn Kelly has agreed ... Dr. Saggau looks forward to Ms. Kelly expanding her ... talents will make her a key contributor. “ Dawn ... educational, professional, and personal experiences that will allow me ...
(Date:9/18/2014)... Memorial Cardiac and Vascular Institute ... by performing the first ever, adult heart transplant in ... Organ Sharing) approval to launch the adult heart transplant ... programs in South Florida. , The skilled cardiac ... Medical Director of the Adult Heart Transplant and ...
(Date:9/18/2014)... to diverse communities may boost infants, social learning, according ... in the park or supermarket could help children be ... different from them, researchers found. "Research has ... interacting with and learning from people who are different ... psychology professor, said in a university news release. ...
(Date:9/18/2014)... Steven Reinberg HealthDay Reporter ... that the Ebola outbreak in West Africa is starting to spread ... than 700 new cases of the deadly viral infection were reported ... cases to more than 5,300, with roughly half of those reported ... The number of deaths now tops 2,600. WHO has estimated ...
Breaking Medicine News(10 mins):Health News:For The First Time in Over a Decade Mercy College Alumni Marry at College 2Health News:Lake Meridian Chiropractic of Kent, WA Announces that Dawn Kelly Has Been Promoted to the Position of Office Manager 2Health News:Memorial Cardiac & Vascular Institute Performs First Adult Heart Transplant in Broward County 2Health News:Memorial Cardiac & Vascular Institute Performs First Adult Heart Transplant in Broward County 3Health News:Memorial Cardiac & Vascular Institute Performs First Adult Heart Transplant in Broward County 4Health News:Study: Exposure to Diversity Might Boost Baby's Social Skills 2Health News:New Ebola Cases Top 700 in Just One Week, Officials Report 2Health News:New Ebola Cases Top 700 in Just One Week, Officials Report 3
... which Highmark employees ... ... 19 nonprofit organizations in Pennsylvania to support programs,with which Highmark employees ... arts and culture education,and raise funds to provide access to health ...
... robot to ... reduces errors and hospital costs, DAYTONA ... in medication error reduction and hospital pharmacy I.V.,room automation, ... system, IntelliFill i.v.(TM), by the Alegent Health System. The,largest ...
... satisfaction survey shows health improvements, disease ... benefits of plan -, ST. LOUIS, Nov. 12 ... 90 percent of members of Care,Improvement Plus feel their health ... satisfaction of the plan,s south central,regional membership. Of those who ...
... published in the November issue of the Springer journal ... absorptiometry has been cut to levels substantially below the ... physicians and clinics around the country are likely to ... access to the test and jeopardizing those at risk ...
... N.C. Heart failure patients who regularly exercise fare ... similar patients who do not work out on a ... , The findings, reported today at the annual meeting ... a long way toward addressing concerns about the value ...
... of more than 800,000 insulin vials to provide free life-saving ... estimated 24,000 children over four years, INDIANAPOLIS, Nov. 12 ... more than 800,000 vials of insulin to,the International Diabetes Federation,s ... many as 24,000 children who currently have,no access to diabetes ...
Cached Medicine News:Health News:Highmark Employee Volunteers Receive $9,500 in Grants for Nonprofit Organizations 2Health News:Highmark Employee Volunteers Receive $9,500 in Grants for Nonprofit Organizations 3Health News:Highmark Employee Volunteers Receive $9,500 in Grants for Nonprofit Organizations 4Health News:Highmark Employee Volunteers Receive $9,500 in Grants for Nonprofit Organizations 5Health News:Highmark Employee Volunteers Receive $9,500 in Grants for Nonprofit Organizations 6Health News:Alegent Health System Automates I.V. Preparation to Enhance Patient Safety 2Health News:Arkansas and Missouri Care Improvement Plus Members Overwhelmingly Pleased with Special Needs Plan 2Health News:Osteoporosis care at risk in the United States 2Health News:Exercise improves quality of life for heart failure patients 2Health News:Exercise improves quality of life for heart failure patients 3Health News:Lilly Announces Major Donation of Insulin to International Diabetes Federation's Life for a Child Program; Initial Focus Will Be on Sub-Saharan Africa 2Health News:Lilly Announces Major Donation of Insulin to International Diabetes Federation's Life for a Child Program; Initial Focus Will Be on Sub-Saharan Africa 3Health News:Lilly Announces Major Donation of Insulin to International Diabetes Federation's Life for a Child Program; Initial Focus Will Be on Sub-Saharan Africa 4
This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 20-200 microliter range....
... ergonomic design reduces hand fatigue, prevents injury. Dry seal technology. No cleaning, ... 20-200 Inaccuracy (%) ... Imprecision(%) ... 1 Dimensions: ...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,411-9) or contact custom...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
Medicine Products: